BioAge Labs, Inc.

BioAge Labs is a drug development company working on treatments for diseases linked to aging, such as heart disease, diabetes, and obesity. The company uses datasets and technology to study how aging changes the body at a molecular level and identify new drug targets. Their main experimental drug, BGE-102, is currently in early human testing for heart disease and eye conditions. BioAge Labs also partners with the pharmaceutical company Novartis to discover new drug targets related to aging.